{"id":68758,"date":"2026-02-21T13:56:34","date_gmt":"2026-02-21T13:56:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68758"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"tb-500","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/tb-500\/","title":{"rendered":"TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 TB-500\u3068\u306f\u4f55\u3067\u3059\u304b\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>TB-500<\/strong> \u306f\u3001\u5408\u6210\u30a2\u30ca\u30ed\u30b0\u3067\u3059 <strong>\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf4<\/strong>, a naturally occurring 43-amino-acid peptide with systemic healing activity. In published preclinical studies it binds G-actin, stimulates angiogenesis via the VEGF\/KDR pathway, and modulates TGF-beta inflammatory signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">77591-33-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u7d044963 Da (N-acetyl Thymosin \u03b2-4 (1\u201343))<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f5c\u696d\u7528\u30b9\u30c8\u30c3\u30af\u306f2\uff5e8\u2103\uff08\u51b7\u8535\u5eab\uff09\u3067\u4fdd\u5b58\u3057\u3001\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u5b58\u306f\u221220\u2103\u3067\u884c\u3044\u307e\u3059\u3002\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u4fdd\u5b58\u3057\u3001\u7d0430\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u6fc0\u3057\u3044\u64b9\u62cc\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002\u5927\u304d\u306a\u30da\u30d7\u30c1\u30c9\u306f\u632f\u76ea\u306b\u3088\u308a\u5909\u6027\u3057\u307e\u3059\u3002\u6eb6\u89e3\u5f8c\u306e\u6eb6\u6db2\u306f\u51cd\u7d50\u878d\u89e3\u3092\u7e70\u308a\u8fd4\u3055\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u306f\u3001\u5408\u6210\u30a2\u30ca\u30ed\u30b0\u306e\u7814\u7a76\u7528\u540d\u79f0\u3067\u3059\u3002<\/h2>\n<p><strong>TB-500<\/strong> is the clinical designation for a synthetic analog of <strong>\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff08TB4\uff09<\/strong>, a naturally-occurring 43-amino-acid peptide hormone found in nearly every cell of the human body. TB4 is most abundant in platelets, and is released at sites of tissue damage where it orchestrates cell migration, angiogenesis, and anti-inflammatory signaling. The synthetic form \u2014 TB-500 \u2014 reproduces the biological activity of TB4 and is the most widely studied compound in this class. The TB4 sequence is <em>Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/em>, molecular weight approximately 4,963\u00a0Da. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/ja\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 guide<\/a>. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 3\u3064\u306e\u7d4c\u8def\u306b\u3088\u308b\u5168\u8eab\u7684\u306a\u6cbb\u7652<\/h2>\n<p>TB-500\u306f\u3001\u307b\u3068\u3093\u3069\u306e\u30da\u30d7\u30c1\u30c9\u3068\u306f\u7570\u306a\u308a\u3001\u305d\u306e <strong>\u5168\u8eab\u5206\u5e03\u3068\u9577\u3044\u8840\u4e2d\u534a\u6e1b\u671f<\/strong>, which allow a single administration to influence repair processes across multiple tissues simultaneously. The three primary mechanistic pathways in published studies:<\/p>\n<ul>\n<li><strong>G-\u30a2\u30af\u30c1\u30f3\u9694\u96e2<\/strong> \u2014 TB-500 binds monomeric actin (G-actin) via a central actin-binding motif (LKKTETQ). This preserves the cytoskeletal reservoir cells need to extend pseudopodia, migrate toward injury sites, and remodel after damage. Cell-migration assays in wound-edge studies consistently show enhanced migration rates in TB4-treated cells.<\/li>\n<li><strong>Angiogenesis via VEGF \/ KDR signaling<\/strong> \u2014 TB-500 stimulates vascular endothelial migration and capillary formation through the VEGF receptor 2 (KDR) pathway. In ischemia-reperfusion and wound-healing studies this translates to faster restoration of perfusion at repair sites.<\/li>\n<li><strong>TGF-\u03b2\u8abf\u7bc0\u3092\u4ecb\u3057\u305f\u6297\u708e\u75c7\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054<\/strong> \u2014 TB-500 reduces pro-inflammatory cytokine release and accelerates resolution of the inflammatory phase of healing. In cardiac ischemia studies, this has been linked to reduced infarct size and preserved cardiomyocyte function.<\/li>\n<\/ul>\n<p>\u3053\u308c\u30893\u3064\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u304c\u5168\u8eab\u306b\u884c\u304d\u6e21\u308b\u305f\u3081\u3001TB-500\u306f\u6ce8\u5c04\u90e8\u4f4d\u304b\u3089\u96e2\u308c\u305f\u7d44\u7e54\u3067\u3082\u52b9\u679c\u3092\u751f\u307f\u51fa\u3057\u307e\u3059\u2014\u3053\u308c\u306f\u3001\u3088\u308a\u5c40\u6240\u7684\u306a\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u3001\u4f8b\u3048\u3070 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a>. The practical consequence: TB-500 protocols are dosed twice weekly rather than daily. <\/p>\n<h2>Published Evidence<\/h2>\n<p>TB-500 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>\u9aa8\u683c\u7b4b\u4fee\u5fa9<\/strong> \u2014 \u632b\u50b7\u3001\u7b4b\u632b\u50b7\u3001\u4e0d\u4f7f\u7528\u6027\u840e\u7e2e\u306e\u3052\u3063\u6b6f\u985e\u30e2\u30c7\u30eb\u306b\u304a\u3051\u308b\u5168\u8eab\u56de\u5fa9\u52d5\u614b<\/li>\n<li><strong>Cardiac recovery<\/strong> \u2014 \u865a\u8840\u5f8c\u306e\u5fc3\u7b4b\u7d30\u80de\u751f\u5b58\u3001\u6897\u585e\u30b5\u30a4\u30ba\u3001\u8840\u7ba1\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\uff08Smart et al., Nature 2011; Bock-Marquette et al., Nature 2004\uff09<\/li>\n<li><strong>\u8171\u304a\u3088\u3073\u976d\u5e2f\u306e\u6cbb\u7652<\/strong> \u2014 \u5358\u72ec\u307e\u305f\u306f\u4f75\u7528 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> in connective-tissue repair studies<\/li>\n<li><strong>\u5168\u8eab\u5275\u50b7\u4fee\u5fa9<\/strong> \u2014 dermal and corneal wound-healing studies, especially where multiple tissue beds are affected<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 follicular angiogenesis and hair-growth phase transitions in rodent study models<\/li>\n<li><strong>\u8840\u7ba1\u4fee\u5fa9<\/strong> \u2014 endothelial cell migration, capillary formation, and ischemia studies<\/li>\n<li><strong>Comparative peptide studies<\/strong> \u2014 \u5c40\u6240\u6cbb\u7652\u306e\u6a19\u6e96\u6bd4\u8f03\u5bfe\u7167\u3067\u3042\u308bBPC-157\u3068\u306e\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u3001\u307e\u305f\u306f <a href=\"https:\/\/medsbase.com\/ja\/igf-1-lr3-peptide-guide\/\">IGF-1 LR3<\/a> KYC\uff08Know Your Customer\uff09 <a href=\"https:\/\/medsbase.com\/ja\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin\/CJC-1295<\/a> in growth-factor studies. See our <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500\u6bd4\u8f03<\/a> \u4e26\u3079\u3066\u6bd4\u8f03\u3057\u305f\u3082\u306e\u3092.<\/li>\n<\/ul>\n<p>TB-500\u304c\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u5168\u4f53\u306e\u4e2d\u3067\u3069\u306e\u3088\u3046\u306b\u4f4d\u7f6e\u3065\u3051\u3089\u308c\u308b\u304b\u3001\u3088\u308a\u5e83\u3044\u6587\u8108\u306b\u3064\u3044\u3066\u306f\u3001\u3054\u89a7\u304f\u3060\u3055\u3044 <a href=\"https:\/\/medsbase.com\/ja\/best-peptides-for-muscle-recovery\/\">\u7b4b\u8089\u56de\u5fa9\u306b\u6700\u9069\u306a\u30da\u30d7\u30c1\u30c9<\/a> cluster article and complementary compounds in the <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a>. <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase\u3067\u306f\u3001TB-500\uff08\u5408\u6210\u30c1\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf4\uff09\u3092\u4ee5\u4e0b\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u30b5\u30a4\u30ba\u3067\u53d6\u308a\u6271\u3063\u3066\u304a\u308a\u307e\u3059\u3002\u5404\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u306f\u300110\u30d0\u30a4\u30a2\u30eb\u300120\u30d0\u30a4\u30a2\u30eb\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb\u306e\u30d1\u30c3\u30af\u5f62\u5f0f\u3067\u767a\u9001\u3055\u308c\u3001\u5b8c\u5168\u306a\u518d\u69cb\u6210\u30ac\u30a4\u30c0\u30f3\u30b9\u3082\u4ed8\u5c5e\u3057\u307e\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot studies, titration, or short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, matches common 2\u20132.5\u00a0mg dose-per-administration protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, bulk prep, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials offer lower per-mg cost and are generally preferred when users are modeling the 2\u20132.5\u00a0mg per-administration dose used across most published TB-500 protocols. <\/p>\n<h2>TB-500\u3068BPC-157\u306e\u6bd4\u8f03<\/h2>\n<p>TB-500\u3068 <a href=\"https:\/\/medsbase.com\/ja\/bpc-157\/\">BPC-157<\/a> are the two most-cited healing peptides. They are often studied together because their mechanisms are complementary rather than overlapping \u2014 BPC-157 acts locally via growth-factor upregulation, TB-500 acts systemically via actin and angiogenesis pathways. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30a2\u30df\u30ce\u9178\u6570<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43\u30a2\u30df\u30ce\u9178\uff08\u7d044,963 Da\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15\u30a2\u30df\u30ce\u9178\uff08\u7d041,419 Da\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e3b\u306a\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">G-\u30a2\u30af\u30c1\u30f3\u6355\u6349\u3001\u8840\u7ba1\u65b0\u751f\u3001TGF-\u03b2<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + GH\u53d7\u5bb9\u4f53\u306e\u4e0a\u65b9\u5236\u5fa1<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5206\u5e03<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5168\u8eab\u6027\u3001\u5e83\u7bc4\u56f2\u306b\u5206\u5e03<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6ce8\u5c04\u90e8\u4f4d\u306b\u3088\u308a\u5c40\u6240\u7684<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\uff5e2.5mg\u3092\u90312\u56de\u30014\uff5e6\u9031\u9593\u306e\u30ed\u30fc\u30c7\u30a3\u30f3\u30b0<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\uff5e500 mcg\u30011\u65e51\uff5e2\u56de<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5fc3\u81d3\u3001\u5168\u8eab\u7b4b\u8089\u3001\u8840\u7ba1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u8171\u3001\u976d\u5e2f\u3001\u8178\u7ba1\u30d0\u30ea\u30a2<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30b9\u30bf\u30c3\u30ad\u30f3\u30b0<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BPC-157\u3068\u4f75\u7528\u3055\u308c\u308b\u3053\u3068\u304c\u4e00\u822c\u7684\u3067\u3059<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">TB-500\u3068\u4f75\u7528\u3055\u308c\u308b\u3053\u3068\u304c\u4e00\u822c\u7684\u3067\u3059<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For the full side-by-side methodological comparison and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: \u3042\u306a\u305f\u306e\u56de\u5fa9\u76ee\u6a19\u306b\u6700\u9069\u306a\u4fee\u5fa9\u30da\u30d7\u30c1\u30c9\u306f\u3069\u3061\u3089\u3067\u3059\u304b\uff1f<\/a>. <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u5143\u306e\u30d1\u30c3\u30b1\u30fc\u30b8\u306e\u307e\u307e2\uff5e8\u2103\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u4e7e\u71e5TB-500\u306f\u3001\u3053\u306e\u6761\u4ef6\u4e0b\u3067\u6700\u957736\u304b\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u7c89\u672b\u306e\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u4e0a\u8a18\u306e\u5e0c\u91c8\u8868\u306b\u5f93\u3044\u3001\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u6ce8\u5165\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u3002\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3066\u304f\u3060\u3055\u3044\u2014\u2014\u884c\u3063\u3066\u304f\u3060\u3055\u3044 <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3063\u3066\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u7f6e\u3044\u3066\u304f\u3060\u3055\u3044\u3002\u6b63\u3057\u304f\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u306f\u305a\u3067\u3059\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> 2\uff5e8\u2103\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3001\u6700\u9069\u306a\u5b89\u5b9a\u6027\u3092\u5f97\u308b\u305f\u3081\u306b30\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u2014\u2014\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u30da\u30d7\u30c1\u30c9\u306e\u5b8c\u5168\u6027\u3092\u52a3\u5316\u3055\u305b\u307e\u3059\u3002\u6fc1\u308a\u3001\u6c88\u6bbf\u3001\u307e\u305f\u306f\u5909\u8272\u304c\u898b\u3089\u308c\u308b\u30d0\u30a4\u30a2\u30eb\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is TB-500 used for in studies?<\/h3>\n<p>TB-500 is used in studies investigating skeletal muscle repair, cardiac recovery, tendon and ligament healing, wound repair, hair-cycle studies, vascular repair, and systemic tissue regeneration. It is <strong>\u3057\u307e\u305b\u3093<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>TB-500\u306fBPC-157\u3068\u3069\u306e\u3088\u3046\u306b\u7570\u306a\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>TB-500 is a 43-amino-acid synthetic analog of Thymosin Beta-4 that acts systemically via G-actin binding, angiogenesis, and TGF-beta signaling. BPC-157 is a 15-amino-acid pentadecapeptide that acts mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. The two are often co-administered in studies because their mechanisms are complementary. <\/p>\n<h3>What is the typical TB-500 dose?<\/h3>\n<p>\u516c\u8868\u3055\u308c\u3066\u3044\u308b\u524d\u81e8\u5e8a\u8a66\u9a13\u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u306f\u3001\u901a\u5e38\u30011\u56de\u3042\u305f\u308a2\uff5e2.5mg\u3092\u90312\u56de\u30014\uff5e6\u9031\u9593\u306e\u5c0e\u5165\u671f\u306b\u6295\u4e0e\u3057\u3001\u305d\u306e\u5f8c\u90311\u56de\u306e\u7dad\u6301\u671f\u306b\u79fb\u884c\u3057\u307e\u3059\u30025mg\u306e\u30d0\u30a4\u30a2\u30eb\u30922.0mL\u306e\u9759\u83cc\u6c34\u3067\u518d\u69cb\u6210\u3059\u308b\u3068\u30012.5mg\/mL\u306e\u6eb6\u6db2\u304c\u5f97\u3089\u308c\u307e\u3059\u3002U-100\u30b7\u30ea\u30f3\u30b8\u306e80\u76ee\u76db\u308a\u30672mg\u304c\u6295\u4e0e\u3055\u308c\u307e\u3059\u3002 <\/p>\n<h3>TB-500\u306fFDA\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. TB-500 (synthetic Thymosin Beta-4) is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>TB-500\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u300136\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\uff1a2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u306e\u7e70\u308a\u8fd4\u3057\u306b\u3088\u308a\u30da\u30d7\u30c1\u30c9\u304c\u5206\u89e3\u3055\u308c\u307e\u3059\u3002 <\/p>\n<h3>TB-500\u306e\u518d\u69cb\u6210\u65b9\u6cd5\u3092\u6559\u3048\u3066\u304f\u3060\u3055\u3044\u3002<\/h3>\n<p>\u4e0a\u8a18\u306e\u6eb6\u89e3\u65b9\u6cd5\u306e\u53c2\u8003\u8868\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u9759\u83cc\u6c34\u3092\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u52a0\u3048\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u3001\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30675\uff5e10\u5206\u9593\u653e\u7f6e\u3057\u307e\u3059\u3002\u884c\u3063\u3066\u304f\u3060\u3055\u3044 <strong>\u3057\u307e\u305b\u3093<\/strong> \u30d0\u30a4\u30a2\u30eb\u3092\u632f\u3063\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u5bb9\u91cf\u306e\u30ec\u30bf\u30eb\u30c8\u30eb\u30c1\u30c9\u3092\u53d6\u308a\u63c3\u3048\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u3067\u306fTB-500\u30922mg\u30015mg\u300110mg\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u3067\u53d6\u308a\u6271\u3063\u3066\u304a\u308a\u307e\u3059\u3002\u5404\u5bb9\u91cf\u306f10\u30d0\u30a4\u30a2\u30eb\u300120\u30d0\u30a4\u30a2\u30eb\u300130\u30d0\u30a4\u30a2\u30eb\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u3059\u3079\u3066\u306e\u30d0\u30a4\u30a2\u30eb\u306f99%\u4ee5\u4e0a\u306eHPLC\u7d14\u5ea6\u3067\u4f9b\u7d66\u3055\u308c\u3001\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5206\u6790\u8a3c\u660e\u66f8\u3092\u63d0\u4f9b\u3044\u305f\u3057\u307e\u3059\u3002 <\/p>\n<h3>Can TB-500 and BPC-157 be stacked in studies?<\/h3>\n<p>Yes. TB-500 and BPC-157 are among the most commonly co-administered peptides in preclinical studies. Their mechanisms are complementary (systemic vs local, actin-binding vs growth-factor-upregulation), and combined protocols appear frequently in connective-tissue and muscle recovery. See our <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">\u6bd4\u8f03\u30ac\u30a4\u30c9<\/a>. <\/p>\n<h3>\u306a\u305cTB-500\u306fBPC-157\u3088\u308a\u3082\u6295\u4e0e\u983b\u5ea6\u304c\u5c11\u306a\u3044\u306e\u3067\u3059\u304b\uff1f<\/h3>\n<p>TB-500 has a longer circulating half-life and distributes systemically, so published studies protocols typically dose twice weekly. BPC-157 is more localized and commonly dosed once or twice daily in the same types of injury-model studies. <\/p>\n<h3>Does TB-500 cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. Published toxicology work has not identified off-target signals at standard doses. <\/p>\n<h3>TB-500\u306f\u5b8c\u5168\u306a\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf4\u3068\u540c\u3058\u3067\u3059\u304b\uff1f<\/h3>\n<p>TB-500 is marketed as a synthetic form of Thymosin Beta-4 (TB4). In commercial supply, what is sold as &#8220;TB-500&#8221; is typically the full 43-amino-acid TB4 molecule synthesized chemically. Some literature refers to shorter actin-binding fragments (LKKTETQ) as functional TB4 analogs in narrow contexts, but full-length TB4 is the dominant form. <\/p>\n<h3>TB-500\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>TB-500 (synthetic Thymosin Beta-4) has an estimated serum half-life of several days in preclinical studies \u2014 significantly longer than most GHRPs and site-specific healing peptides such as BPC-157. This extended half-life supports the less-frequent dosing schedules typically used in T\u03b24 protocols. <\/p>\n<h3>How long does TB-500 take to show effects in preclinical studies?<\/h3>\n<p>Preclinical studies using Thymosin Beta-4 in cardiac, skeletal muscle, and connective tissue models typically observe measurable effects over 2\u20134 week cycles. The systemic distribution and longer half-life compared to site-directed peptides mean TB-500 timelines are generally extended. <\/p>\n<h3>TB-500\u3092\u56fd\u969b\u914d\u9001\u3067\u6ce8\u6587\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002MedsBase\u3067\u306f\u3001\u30da\u30d7\u30c1\u30c9\u5c02\u7528\u306e\u767a\u9001\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u304b\u3089TB-500\u3092\u5168\u4e16\u754c\u914d\u9001\u3057\u3066\u3044\u307e\u3059\u3002\u30da\u30d7\u30c1\u30c9\u306e\u307f\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f0a\u793e\u306e\u30da\u30d7\u30c1\u30c9\u5c02\u7528\u767a\u9001\u30b5\u30fc\u30d3\u30b9\u306e\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002\u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u6e29\u5ea6\u7ba1\u7406\u3055\u308c\u305f\u68b1\u5305\u3067\u3001\u8ffd\u8de1\u30b5\u30fc\u30d3\u30b9\u4ed8\u304d\u3067\u767a\u9001\u3055\u308c\u307e\u3059\u3002 <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">TB-500\u306f\u3001BPC-157\u3068\u4f75\u7528\u3055\u308c\u308b\u3053\u3068\u304c\u6700\u3082\u591a\u304f\u3001\u8840\u7ba1\u65b0\u751f\uff08BPC-157\uff09\u3068\u7d30\u80de\u9aa8\u683c\u4fee\u5fa9\uff08TB-500\uff09\u306e\u7d44\u307f\u5408\u308f\u305b\u306b\u3088\u308a\u3001\u3069\u3061\u3089\u304b\u4e00\u65b9\u306e\u30da\u30d7\u30c1\u30c9\u5358\u72ec\u3088\u308a\u3082\u8fc5\u901f\u304b\u3064\u5b8c\u5168\u306a\u8edf\u90e8\u7d44\u7e54\u306e\u56de\u5fa9\u304c\u5f97\u3089\u308c\u307e\u3059\u3002\u5f53\u793e\u306e <a href=\"\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af (BPC-157 5 mg + TB-500 5 mg + bacteriostatic water)<\/a> \u4e00\u81f4\u3059\u308b\u30d7\u30ed\u30c8\u30b3\u30eb\u30921\u3064\u306e\u5c0f\u5305\u3067\u767a\u9001\u3057\u307e\u3059\u3002<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/ja\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/ja\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 \u9078\u629e\u7684\u30b0\u30ec\u30ea\u30f3\u4f5c\u52d5\u85ac \u2014 \u30b3\u30eb\u30c1\u30be\u30fc\u30eb\uff0f\u30d7\u30ed\u30e9\u30af\u30c1\u30f3\u3092\u4f34\u308f\u306a\u3044\u30af\u30ea\u30fc\u30f3\u306aGH\u30d1\u30eb\u30b9<\/li>\n<li><a href=\"\/ja\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 \u534a\u6e1b\u671f\u5ef6\u9577\u578bGHRH\u30a2\u30ca\u30ed\u30b0<\/li>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/ja\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/tb-500-thymosin-beta-4-peptide-guide\/\"><strong>TB-500 \u2014 \u4f5c\u7528\u6a5f\u5e8f\u3001\u8a66\u9a13\u30c7\u30fc\u30bf\u3068\u5c55\u671b<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u7d30\u80de\u518d\u751f\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u7d44\u7e54\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u3092\u4fc3\u9032<br \/>\n\u2705 \u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u3092\u4fc3\u9032<br \/>\n\u2705 \u8840\u7ba1\u65b0\u751f\u30b7\u30b0\u30ca\u30eb\u3092\u523a\u6fc0<br \/>\n\u2705 \u7d30\u80de\u5916\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u306e\u5b89\u5b9a\u6027\u3092\u5411\u4e0a<\/p>\n<p><strong>TB-500<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70987,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,5442,5443],"class_list":["post-68758","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-tb-500","product_tag-thymosin-beta-4","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/68758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=68758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70987"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=68758"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=68758"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=68758"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=68758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}